27.5 C
Vientiane
Saturday, June 21, 2025
spot_img
Home Blog Page 519

QC Ware Announces 4th Q2B Tokyo Conference Focused on the Roadmap to Quantum Value in Asia and Beyond, Quemix to Co-host and Sponsor

QC Ware hosts the 4th Q2B conference in Tokyo to connect the Asian and global quantum technology landscape and bring together quantum industry experts across computing, AI, telecommunications, sensing, finance, automotive, chemicals, and more.

PALO ALTO, Calif., April 7, 2025 /PRNewswire/ — QC Ware, a leading provider of industry-disrupting quantum technology, quantum-inspired machine learning, and quantum chemistry simulation solutions, today announced the 2025 Q2B Tokyo Conference (Q2B25) taking place May 15-16, 2025.

As the Q2B25 Tokyo Co-host and Platinum Sponsor, Quemix will contribute to discussions and demonstrations aimed at accelerating the adoption of quantum technologies in various industries, spanning pharmaceutical, biotech, finance, automotive, logistics, and artificial intelligence. “Quemix is honored to be a co-host of Q2B Tokyo 2025. We’re incredibly excited to see the robust ecosystem that will shape the future of quantum technology being built here,” said Quemix CEO and President, Yu-ichiro Matsushita.

The conference, being held at the Grand Hyatt Tokyo, will dive deep into all major quantum technologies and themes: computing, sensing, communications, security, error correction, quantum AI, HPC integration, and more. Attendees can expect to see featured keynotes, industry case studies, and discussions led by experts at the forefront of quantum R&D from some of the world’s leading businesses and institutions across government, academia, and industry.

“It’s a pleasure to be back in Tokyo for another Q2B event. Japan’s quantum community continues to impress with its innovation, collaboration, and global leadership.  The strong engagement of Japanese industrial end users, who are actively exploring and adopting quantum technologies, drive real-world impact across various sectors.  We’re excited to engage with this vibrant landscape shaping the future of quantum,”  said QC Ware CEO, Matt Johnson. “The quantum ecosystems of Japan and Asia are incredibly dynamic and exciting, and the work undertaken to directly and indirectly create that environment cannot be overstated.”

Through keynotes, business seminars, breakout sessions, technical workshops, and panel discussions, attendees at Q2B Tokyo will learn about the latest hardware and software breakthroughs as well as applications in optimization, chemistry simulations, pharmaceutical and materials discovery, error correction, and quantum AI. Additionally, the conference features several panels and sessions from field practitioners, end users, and experts across industries. Notable speakers include:

  • Jingo Kikukawa – Director-General, Innovation and Environment Policy Bureau, Ministry of Economy Trade and Industry (METI)
  • Taro Shimada – Chair of the Board, Quantum Strategic Industry Alliance for Revolution (Q-STAR) and CEO, Toshiba
  • Prof Seigo Tarucha – Research Group Director, RIKEN
  • Yu-ichiro Matsushita – CEO, Quemix
  • Shuya Kekke – CEO and Representative Director, Quantinuum K.K.
  • Dr. Michael J. Biercuk – CEO and Founder, Q-CTRL
  • Seiji Kihara – Member of the House of Representatives /Chairperson, Election Strategy Committee, Liberal Democratic Party
  • D. Eng. Seiji Yunoki – Team Leader, RIKEN
  • Yoshihiro Maeda – Chief Growth Officer, Deloitte Tohmatsu
  • Doug Finke – Chief Content Officer, GQI

Q2B is dedicated to promoting and growing the quantum technologies landscape with applied implementation examples via the case studies track. This track is dedicated to real-world applications of quantum technologies and provides case studies from industrial end users who have already started their quantum journey. Leaders charting the future of quantum technology adoption will deliver sessions on recent advancements in the field, including:

  • Qi Gao – Senior Chief Scientist, Mitsubishi Chemical Corporation
  • Carmen Palacios – Founder and CEO, Nu Quantum
  • Oded Melamed – CEO and Co-founder, Quantum Source
  • Dr. Netanel Lindner – Professor of Physics, Co-founder and CTO, Qedma
  • Constanza Vidal Bustamente – Fellow, Technology and National Security, Center for a New American Security
  • Shaukat Ali – Chief Research Scientist, Simula Research Laboratory
  • Masahiro Horibe – Deputy Director, AIST/G-QuAT
  • Marcus Doherty – Co-founder and CTO, Quantum Brilliance
  • Dr. Shintaro Sato – Head of Quantum Lab, Fujitsu Research
  • Masaru Watabiki – Senior Expert, Toshiba Digital Solutions Corporation
  • Vladimir Tsitrin – Quantum Security Research Lead, Fidelity Center for Applied Technology
  • Shihan Sajeed – Program Director, Wellcome Leap
  • Shunsuke Okada – Executive Director, Q-STAR

Attendees will also have the opportunity to explore the exhibit floor with vendors showcasing their latest advancements in quantum technologies, featuring: Quemix, Keysight, Quantinuum, QuEra Computing, Qedma, Quantum Machines, IonQ, Toshiba, Fujitsu, RIKEN, Classiq, Oxford Quantum Circuits, IQM, Toyota Tsusho, Lquom, NF Corporation, Alpine Quantum Technologies, Q-STAR, and more.

Find the agenda, featured speakers and register to attend Q2B25 Tokyo here.

About QC Ware
QC Ware is a quantum and classical computing SaaS company focused on delivering enterprise value through cutting-edge computational technology. The company develops enterprise-grade applications that run on state-of-the-art classical computing hardware and algorithms targeting near-term quantum hardware. Its flagship product, Promethium, is an advanced molecular discovery platform that leverages quantum chemistry to accelerate research across pharmaceutical, materials science, and chemical industries. With specialization in machine learning and chemistry simulation applications, the team bridges the gap between theoretical quantum computing and practical business solutions. Composed of some of the industry’s foremost experts, QC Ware is headquartered in Palo Alto, California, with a European subsidiary in Paris. The company also organizes Q2B, a global series of conferences for industry, practitioner, and academic quantum computing communities. Learn more at www.qcware.com.

CONTACT: Jean-Baptiste Faverjon, +33777847234, jb.faverjon@qcware.com 

Trip.com Kicks Off Mega Sale on Flights & Hotels to Celebrate Easter

SYDNEY, April 7, 2025 /PRNewswire/ — Trip.com is thrilled to launch its Easter Mega Sale, offering an array of exciting travel deals and exclusive promotions. Get ready to pack your bags to your dream destination. From 1 April to 27 April, Trip.com is offering fantastic discounts with promo codes for up to 50% off flights and accommodation, making it easier than ever to save big and explore the world.


Unlock Unbeatable Airfare Deals

Whether you’re looking to hop on a staycation or jet-set internationally, Trip.com has you covered.  Customers can save more than AU$1,000 this Easter Sale with airline promo codes from China Eastern Airlines, Scoot, Air India, Sichuan Airlines, and more, available starting 9 am AEST on 8 April. Plus, customers still have the chance to get flight promo codes worth up to 50% off. Offer starts 12 pm AEST on 8 April until 11:59 pm AEST on 8 April, on a first-come, first-served basis, while stocks last.

Customers can also grab unbeatable deals on international and domestic flights during Trip.com’s #TripTuesday Flight Flash Sale. One-way flights between Sydney, Melbourne, Brisbane, Adelaide and the Gold Coast start from just AU$29, including taxes and fees.  Only one order per customer, subject to T&Cs.

Alternatively, travellers looking to explore Bali’s vibrant streets and pristine beaches can fly from Perth to Bali one way for an incredible price of AU$109.

Stay & Play with a Fantastic Hotel Giveaway 

Trip.com customers can win a 3-night stay in a luxurious suite at Le Méridien Melbourne, offering you an exceptional birds-eye view over the bustling streets of Melbourne. A daily buffet breakfast for two adults and VIP Valet parking is included. All you have to do is enter the giveaway via Instagram. The winner will be announced on Tuesday, 29 April.

Browse even more hotel deals and save on stays with up to 50% off hotel promo codes, available from 3 pm AEST on 15 April until 11:59 pm AEST on 15 April, on a first-come, first-served basis, while stocks last.  

 Other Easter Mega Sale highlights include:

  • Enjoy up to $15 off top attractions, or pick up Buy 1 Get 1 on Universal Studios Singapore and Universal Studios Japan.
  • Stay connected with 50% off eSIMs.

Don’t miss out! Book your dream vacation with the best promotions and save big this holiday. Visit Trip.com’s Easter Sale for full T&Cs and start planning your next getaway, or download the Trip.com app by scanning the QR code on the website.

About Trip.com

Trip.com is an international one-stop travel service provider, available in 24 languages across 39 countries and regions in 35 local currencies. Trip.com has an extensive hotel and flight network consisting of more than 1.7 million hotels and flights from over 600 airlines covering 3,400 airports in 220 countries and regions around the globe. Trip.com’s world-class 24/7 multilingual customer service, as well as additional centres in Edinburgh, Tokyo and Seoul, help to ‘create the best travel experience’ for its millions of customers worldwide. To book your next trip, visit trip.com.

 

Advancing Circular Economy: Sorbent Tissues Drive Sustainable Solutions in Australia

JAKARTA, Indonesia, April 7, 2025 /PRNewswire/ — The Australian government recently introduced the Circular Economy Framework, a strategic initiative designed to boost sustainability and economic growth. The framework aims to double the country’s circularity by 2025, potentially adding $26 billion to the GDP by 2035 and reducing greenhouse gas emissions by 14%.

With sustainability driving business growth, 67% of Australian companies report financial benefits from their green strategies, according to SAP. Sustainable products may have higher upfront costs, the long-term advantages, such as improved efficiency, stronger brand reputation, and increased customer loyalty, outweigh the initial investment. As a result, more businesses are prioritizing sustainability, with 49% planning to increase spending over the next three years, up from 38% last year.

Aligning with this momentum, APP Group, through its strategic supply partnership with Sorbent, integrates sustainability into its operations in Australia, embedding eco-friendly practices to support the country’s circular economy.”

“At Sorbent we understand that toilet paper is a basic necessity in Australia, and we are committed to ensuring this essential product is produced sustainably,” stated Steve Nicholson, ANZ Director for Sorbent Paper Company. “We aim to support the Australian government’s new Circular Economy Framework and assist businesses in adopting sustainable practices as well.”

Sustainability plays a key role in how Sorbent manages their product manufacturing. Sorbent uses fibers from responsibly managed plantations, where fast-growing trees enable them to use less land while maintaining high product quality. Sorbent is PEFC-certified (Programme for the Endorsement of Forest Certification), ensuring that 100% of its raw materials are either PEFC CoC certified or sourced responsibly in accordance with PEFC guidelines.

Sorbent actively support Australia’s sustainability efforts by prioritizing responsible sourcing, efficient manufacturing, and eco-friendly innovations. Their commitment drives industry progress while meeting the increasing demand for sustainable products.

About APP Group

APP is a leading pulp, paper, and forestry company based in Indonesia, supplying high-quality tissue, packaging, and paper to over 150 countries. With operations in Indonesia and China, we prioritize sustainability, ethical practices, and the well-being of our employees, society, and the environment. Our Sustainability Roadmap Vision 2030, aligned with ESG principles, guides our efforts in environmental protection, community support, biodiversity preservation, and carbon neutrality.

 

/R E P E A T — MEDIA ADVISORY – Canada’s No. 1 Hospital to announce strategy to attract world’s most promising scientists to drive health innovation and economic growth/

TORONTO, April 6, 2025 /PRNewswire/ —

WHAT: Canada’s No. 1 Hospital, University Health Network (UHN) is unveiling an ambitious strategy aimed at attracting the brightest minds in medical research to Canada, whose work will help fuel economic development, Canadian-based manufacturing and high-quality jobs.

WHEN: Monday, April 7, 2025, at 11:30 a.m. — Media, please arrive 15 minutes prior.

WHERE: UHN’s Toronto General Hospital, 200 Elizabeth Street, Toronto, ON  

WHO: 

  • Hon. Doug Ford, Premier of Ontario 
  • Hon. Sylvia Jones, Deputy Premier of Ontario and Minister of Health 
  • Dr. Kevin Smith, President & CEO, UHN 
  • Dr. Brad Wouters, Executive Vice President, Science & Research, UHN 
  • Mr. Cornell Wright, Deputy Chair, UHN Board of Trustees 

Remarks will start promptly at 11:45 a.m. 

For those outside the city of Toronto, event will be live streamed starting 11:45 am 

More information at www.UHNCanadaleads.ca  

RSVP: Please send confirmation of journalists attending to ana.fernandes@uhn.ca  

The Phase III Study Data of Stapokibart for Seasonal Allergic Rhinitis Published in Nature Medicine

CHENGDU, China, April 6, 2025 /PRNewswire/ — Keymed Biosciences Inc. (HKEX: 02162) (“Keymed” or the “Company”) today announced that the prestigious medical journal Nature Medicine has published the results from the Phase III trial of its independently developed IL-4Rα antibody stapokibart, for the treatment of moderate-to-severe seasonal allergic rhinitis (SAR). The study, led by Professor Luo Zhang of Beijing Tongren Hospital, Capital Medical University, represents the world’s first clinical report on an IL-4Rα-targeted biologic for SAR, underscoring Chinese scientists’ pioneering role in allergic rhinitis innovation.

The study demonstrated that stapokibart significantly alleviates clinical symptoms and improves quality of life in patients with moderate-to-severe SAR who remained inadequately controlled despite standard therapies. This breakthrough offers a transformative solution to a global health challenge, ushering in a new era of biologic treatments for allergic rhinitis and providing hope to hundreds of millions of patients worldwide. 

Innovative Mechanism Addresses Urgent Clinical Needs

Allergic rhinitis (AR), a chronic inflammatory disease of the nasal mucosa, is triggered by environmental allergens in sensitized individuals. In recent years, its global prevalence has risen significantly. Despite standard therapies, over 50% of patients continue to experience inadequately controlled symptoms, a substantial unmet need that severely impacts quality of life and imposes a heavy socioeconomic burden, positioning AR as a critical public health challenge.

The persistence and exacerbation of AR symptoms are primarily driven by amplified type 2 inflammatory cascades. Stapokibart, targeting the IL-4 receptor alpha subunit (IL-4Rα), dual-blocks both IL-4 and IL-13 signaling pathways. Through a multi-pronged approach—inhibiting T-cell activation and proliferation, suppressing B-cell activation and IgE synthesis, and reducing inflammatory cell infiltration—Stapokibart comprehensively attenuates allergic reactions, providing a novel therapeutic strategy for seasonal allergic rhinitis, and other type 2-mediated allergic diseases.

The First and Only Approved IL-4Rα Antibody Globally with Demonstrated Efficacy and Safety

Results of this phase III trial demonstrated that stapokibart rapidly, significantly, and sustainably controlled both nasal and ocular symptoms in patients with moderate-to-severe SAR, while markedly improving quality of life and maintaining a favorable safety profile.

Rapid, potent and sustained control of nasal symptoms:

Rapid relief of nasal obstruction: Compared to placebo group, patients in stapokibart group achieved significantly greater improvement in nasal congestion symptom at Day 2. By Day 7, 72% of patients reported clear nasal breathing, with the cumulative response rate rising to 86% at Week 2 and 94% at Week 4.

Potent and sustained control of nasal symptoms: Stapokibart demonstrated a 2.7-point reduction in daily reflective total nasal symptom score (rTNSS) from baseline by Day 4, significantly greater than the improvement in the placebo group.

Over the 2-week treatment period, stapokibart achieved a 3.6-point reduction in daily rTNSS from baseline, with a least squares (LS) mean difference of -1.3 points vs. placebo (the primary efficacy endpoint). Additionally, 62% of patients achieved mild or no symptom (defined as rTNSS ≤1 point for each symptom); Over the 4-week treatment period, the stapokibart group showed a 4.9-point reduction in daily rTNSS from baseline, with an LS mean difference of -1.7 points vs. placebo. The proportion of patients achieving mild or no nasal symptoms reached 84%.

Sustained and significant improvement of ocular symptoms:

Stapokibart demonstrated clinically significant reductions in the daily reflective Total Ocular Symptom Score (rTOSS) from baseline, with improvements of 2.6 points at week 2 and 3.7 points at week 4 respectively, both significantly superior to placebo. By Week 2, 62% of patients achieved mild or no ocular symptoms (defined as rTOSS ≤1 point for each symptom), increasing to 94% by Week 4.

Significant reduction in levels of type 2 inflammatory biomarkers

During the 4-week treatment period, the stapokibart group demonstrated significant reductions in total serum IgE levels and allergen-specific IgE (sIgE) levels against pollen allergens.

Additionally, stapokibart reduced type 2 inflammatory biomarker levels in nasal secretions, including cystatin SN (CST1) and eotaxin-3, demonstrating its dual mechanism of action: targeting both the underlying etiology (type 2 inflammation) and symptomatic manifestations of allergic rhinitis.

Safety

Stapokibart demonstrated a favorable safety profile in patients with seasonal allergic rhinitis. The incidence of treatment-emergent adverse events (TEAEs) was comparable to placebo, and no serious adverse events (SAEs) were reported during the trial.

Groundbreaking Research Ushers in a New Era of Biologic Therapy for Allergic Rhinitis

The PHECDA trial pioneered targeted biologic therapy for allergic rhinitis. The results supported the approval of stapokibart—the world’s first and only IL-4Rα monoclonal antibody for seasonal allergic rhinitis (SAR)— by China’s National Medical Products Administration (NMPA) on February 7, 2025. This breakthrough provides a novel therapeutic option for patients with moderate-to-severe refractory SAR, solidifying Chinese clinical scientists’ global leadership in allergic rhinitis research and setting a precedent for future clinical development.

Stapokibart, a Category 1 New Drug independently developed by Keymed, is China’s first domestically developed and one of the only two approved IL-4Rα antibody drugs worldwide. Since its initial NMPA approval in September 2024, stapokibart has secured three indications, including moderate-to-severe atopic dermatitis in adults, chronic rhinosinusitis with nasal polyposis(CRSwNP), and SAR,  within six months, addressing critical unmet needs. With spring—the peak season for SAR—approaching, stapokibart offers patients a novel treatment leveraging its precision targeting of type 2 inflammation and robust clinical efficacy.

Keymed focuses on high-value unmet medical needs, delivering high-quality, accessible, and innovative therapies for patients globally. The company has now established a diverse proprietary R&D platform and a differentiated pipeline with industry-leading candidates. With a comprehensive biopharmaceutical industry layout spanning from molecular discovery to commercial-scale production, Keymed is accelerating the availability of transformative medicines.

About Stapokibart

Stapokibart (CM310) is a high-efficient, humanized antibody targeting the interleukin-4 receptor alpha subunit (IL-4Rα), and is the first domestically manufactured IL-4Rα antibody drug granted marketing approval by the NMPA. By targeting IL-4Rα, Stapokibart can block both interleukin-4 (IL-4) and interleukin-13 (IL-13) signaling. IL-4 and IL-13 are two key cytokines trigger type II inflammation. Stapokibart has demonstrated a favorable safety profile and encouraging efficacy across multiple clinical trials and has been approved for marketing for the treatment of moderate to severe atopic dermatitis in adults, chronic rhinosinusitis with nasal polyposis, and Seasonal Allergic Rhinitis in September 2024, December 2024 and February 2025, respectively.

About Keymed Biosciences Inc.

Keymed Biosciences Inc. (HKEX: 02162) focuses on the urgent unmet clinical needs and is committed to providing high-quality, affordable, innovative therapies for patients in China and overseas. Keymed was founded by medical and scientific experts who have strong experience in the transformation of scientific and technological achievements to commercialization at home and abroad.

InvestHK visits Middle East to attract business investment to Hong Kong


HONG KONG SAR – Media OutReach Newswire – 6 April 2025 – ​Associate Director-General of Investment Promotion at Invest Hong Kong (InvestHK) Mr Charles Ng will commence his duty visit to the Middle East from today (April 6) to April 10, with key engagements in Saudi Arabia and the United Arab Emirates (UAE). The visit underscores Hong Kong’s commitment to deepening economic ties with these dynamic markets and promoting the city as a premier gateway for Middle Eastern businesses seeking opportunities on the Mainland and in the broader Asia-Pacific region.

20250402 Charle pre duty visit photo1

Hong Kong has a strong, long-standing and ever-growing relationship with the Gulf region including Saudi Arabia and the UAE, marked by increasing co-operation in finance, trade, and investment. The city’s merchandise trade with the Cooperation Council for the Arab States of the Gulf reached US$21.6 billion in 2023. These partnerships are further strengthened through initiatives such as the Belt and Road Initiative, which fosters greater connectivity and economic opportunities.

“Amid an increasingly complex global landscape and geopolitical uncertainties, countries in the Middle East are actively diversifying their investments. Hong Kong, as a global financial centre and a ‘super connector’ between the Mainland, Asia, and the rest of the world, is uniquely positioned to support this shift,” said Mr Ng. “Under the ‘one country, two systems’ principle, our city offers a robust legal system, free flow of capital and information, and internationally aligned regulations. Beyond finance, Hong Kong is also a hub for trade, logistics, innovation and professional services. It serves as a gateway for Middle Eastern partners to tap into the Mainland and the broader Asia-Pacific region.”

As part of its commitment to financial diversification, the city has developed a supportive platform for Islamic finance, including sukuk issuance and tax law amendments to ensure a level playing field with conventional bonds and the successful launch of three government sukuk. It continues to welcome more Islamic financial institutions and products to leverage Hong Kong’s international financial platform and tap into opportunities across Asia and the Mainland.

During his visit to Riyadh, Jeddah and Dubai, Mr Ng will participate in numerous high-level business roundtables co-organised with Asia House, bringing together representatives from prominent businesses, family offices, and investors. He will also meet with representatives from leading Middle Eastern companies and discuss how establishing a presence in Hong Kong can drive their global expansion strategies.

These engagements aim to strengthen economic ties, foster collaboration, and attract more businesses from the Middle East to invest and expand through Hong Kong. By leveraging Hong Kong’s unique position as a global financial and multinational supply chain management hub, InvestHK seeks to facilitate mutually beneficial partnerships that drive innovation and growth across regions.Hashtag: #InvestHK

The issuer is solely responsible for the content of this announcement.

BREAKTHROUGH PRIZE ANNOUNCES 2025 LAUREATES IN LIFE SCIENCES, FUNDAMENTAL PHYSICS, AND MATHEMATICS

“Oscars® of Science” Awards Six $3 Million Prizes

GLP-1 Diabetes and Obesity Discovery | Multiple Sclerosis Causes and Treatments | DNA Editing

Exploration of Nature at Shortest Distances 

Proof of Geometric Langlands Conjecture

Special Prize Awarded to Giant of Theoretical Physics

Breakthrough Prize in Life Sciences Awarded to Daniel J. Drucker, Joel Habener, Jens Juul Holst, Lotte Bjerre Knudsen and Svetlana Mojsov; Alberto Ascherio and Stephen L. Hauser; and David R. Liu

Breakthrough Prize in Fundamental Physics Awarded to More than 13,000 Researchers from ATLAS, CMS, ALICE and LHCb Experiments at CERN

Breakthrough Prize in Mathematics Awarded to Dennis Gaitsgory

Special Breakthrough Prize in Fundamental Physics Awarded to Gerardus ‘t Hooft

Six New Horizons Prizes Awarded for Early-Career Achievements in Physics and Mathematics

Three Maryam Mirzakhani New Frontiers Prizes Awarded to Women Mathematicians
for Early-Career Work

Laureates Announced and Honored at Annual Breakthrough Prize Ceremony in Los Angeles

LOS ANGELES, April 6, 2025 /PRNewswire/ — The Breakthrough Prize Foundation today announced the winners of the 2025 Breakthrough Prizes, honoring scientists driving remarkable discoveries in gene editing, human diseases, the fundamental particles of the Universe and its underlying mathematical principles.

The Breakthrough Prize – popularly known as the “Oscars® of Science” – was created to celebrate the wonders of our scientific age by founding sponsors Sergey Brin, Priscilla Chan and Mark Zuckerberg, Julia and Yuri Milner, and Anne Wojcicki.

Six Breakthrough Prizes of $3 million each were awarded in Life Sciences, Fundamental Physics, and Mathematics. In addition, the foundation announced eight early-career physicists and mathematicians are sharing six $100,000 New Horizons Prizes. Three women mathematicians recently completing PhDs are each receiving a $50,000 Maryam Mirzakhani New Frontiers Prize. This year’s prize money totals $18.75 million, bringing the amount conferred over the 14 years of the Breakthrough Prize to more than $326 million.

“This year’s Breakthrough Prize laureates have made amazing strides – including treatments for major diseases affecting millions of people worldwide – showing once again the transformative power of curiosity-driven basic science.”
Priscilla Chan and Mark Zuckerberg

“The questions these laureates are asking are among the deepest questions there are – about the workings of life, the nature of the Universe and the abstract landscapes of mathematics. It’s inspiring to see scientists seeking and finding answers to these questions.”
Yuri Milner

“The breakthroughs being recognized this year are extraordinary – including, in my own field, amazing gene-editing technologies that are already having a big impact. I’m excited to learn more about the scientists’ ideas across all the fields.” 
– Anne Wojcicki

Life Sciences

Daniel J. Drucker, Joel Habener, Jens Juul Holst, Lotte Bjerre Knudsen and Svetlana Mojsov share the Breakthrough Prize in Life Sciences. These five scientists’ complementary contributions – from basic hormone discovery through physiological understanding to pharmaceutical development – have led to highly effective drugs for diabetes and obesity, ushering in a new era of GLP-1 medicines for cardiometabolic disorders. Between them their breakthroughs include: the discovery of the gene encoding the GLP-1 hormone; the synthesis, isolation and characterization of the hormone’s biologically active forms; the demonstration that it is produced in the gut and stimulates insulin production; elucidation of its broader physiological roles, including control of appetite and energy homeostasis; the development of a more stable version of the hormone that continues to act in the body for days rather than hours; and its translation into a new class of drugs that is transforming the treatment of metabolic diseases affecting hundreds of millions of people worldwide.

Stephen L. Hauser and Alberto Ascherio share the Breakthrough Prize in Life Sciences. The two researchers have transformed the understanding and treatment of multiple sclerosis (MS), a debilitating neurodegenerative disease in which the immune system attacks the insulating protein around nerve fibers. Among other contributions, Hauser overturned the scientific consensus on the mechanism of MS, identifying the immune system’s B cells as the primary driver of damage to nerve cells. He was also instrumental in the development and testing of B cell-depleting therapies, which have revolutionized modern treatment of the disease. Meanwhile, through painstaking long-term epidemiological analysis, Ascherio discovered the necessary condition for getting MS: infection with the Epstein-Barr virus (EBV). The majority of the population carries this pathogen, normally without severe effects, but Ascherio showed that contracting it raises the risk of developing MS by a factor of 32. This work opens the possibility of treating MS with antiviral drugs, and for the development of a vaccine for EBV that could effectively prevent MS altogether.

David R. Liu is awarded the Breakthrough Prize in Life Sciences for developing two powerful, widely used gene-editing technologies. These technologies are engineered molecular machines that correct mutations in our DNA that cause genetic diseases in patients. Importantly, they do not require cutting the DNA double-helix, and thus lead to fewer unwanted outcomes. In 2016 Liu’s lab developed base editing, which corrects the single-letter “misspellings” that constitute about 30 percent of mutations known to cause genetic diseases. Then in 2019 his lab invented prime editing, which replaces whole stretches of defective DNA with a corrected version, and in principle could be used to repair nearly all disease-causing mutations. These technologies have already been distributed more than 20,000 times to labs around the world, resulting in thousands of published advances in research, agriculture, and biomedicine. In animals, base editing and prime editing have successfully corrected mutations to rescue blood diseases such as sickle-cell disease and beta-thalassemia, neurological disorders such as ALS and spinal muscular atrophy (SMA), muscle diseases such as muscular dystrophy and cardiomyopathies, genetic forms of blindness, genetic forms of hearing loss, several metabolic disorders, and progeria, a premature aging disease. At least 15 base editing and prime editing clinical trials have begun in five countries, with beneficial and, in some cases, life-saving results already confirmed in patients for the treatment of T-cell leukemia, sickle-cell disease, beta-thalassemia, and high cholesterol.

Fundamental Physics

The Breakthrough Prize in Fundamental Physics is awarded to thousands of researchers from more than 70 countries representing four experimental collaborations at CERN‘s Large Hadron Collider (LHC) – ATLAS, CMS, ALICE and LHCb.

The $3 million prize is allocated to ATLAS ($1 million); CMS ($1 million), ALICE ($500,000) and LHCb ($500,000), in recognition of 13,508 co-authors of publications based on LHC Run-2 data released between 2015 and July 15, 2024. [ATLAS – 5,345 researchers; CMS – 4,550; ALICE – 1,869; LHCb – 1,744]. 

In consultation with the leaders of the experiments, the Breakthrough Prize Foundation will donate 100 percent of the prize funds to the CERN & Society Foundation. The prize money will be used by the collaborations to offer grants for doctoral students from member institutes to spend research time at CERN, giving the students experience working at the forefront of science and new expertise to bring back to their home countries and regions.

The four experiments are recognized for testing the modern theory of particle physics – the Standard Model – and other theories describing physics that might lie beyond it to high precision. This includes precisely measuring properties of the Higgs boson and elucidating the mechanism by which the Higgs field gives mass to elementary particles; probing extremely rare particle interactions, and exotic states of matter that existed in the first moments of the Universe; discovering more than 72 new hadrons and measuring subtle differences between matter and antimatter particles; and setting strong bounds on possibilities for new physics beyond the Standard Model, including dark matter, supersymmetry and hidden extra dimensions. ATLAS and CMS are general-purpose experiments, which pursue the full program of exploration offered by the LHC’s high-energy and high-intensity proton and ion beams. They synchronously announced the discovery of the Higgs boson in 2012 and continue to investigate its properties. ALICE studies the quark-gluon plasma, a state of extremely hot and dense matter that existed in the first microseconds after the Big Bang. And LHCb explores minute differences between matter and antimatter, violation of fundamental symmetries, and the complex spectra of composite particles (“hadrons”) made of heavy and light quarks. By performing these extraordinarily precise and delicate tests, the LHC experiments have pushed the boundaries of fundamental physics to unprecedented limits.

Mathematics

Dennis Gaitsgory wins the Breakthrough Prize in Mathematics for his central role in the proof of the geometric Langlands conjecture. The Langlands program is a broad research program spanning several fields of mathematics. It grew out of a series of conjectures proposing precise connections between seemingly disparate mathematical concepts. Such connections are powerful tools; for example, the proof of Fermat’s Last Theorem reduces to a particular instance of the Langlands conjecture. These Langlands program equivalences can be thought of as generalizations of the Fourier transform, a tool that relates waves to frequency spectrums and has widespread uses from seismology to sound engineering. In the case of the geometric Langlands conjecture, the proposed one-to-one correspondence is between two very different sets of objects, analogous to these spectrums and waves: on the spectrum side are abstract algebraic objects called representations of the fundamental group, which capture information about the kinds of loop that can wrap around certain complex surfaces; on the “wave” side are sheaves, which, loosely speaking, are rules assigning vector spaces to points on a surface. Gaitsgory has dedicated much of the last 30 years to the geometric Langlands conjecture. In 2013 he wrote an outline of the steps required for a proof, and after more than a decade of intensive research in 2024 he and his colleagues published the full proof, comprising over 800 pages spread over 5 papers. This is a monumental advance, expected to have deep implications in other areas of mathematics too, including number theory, algebraic geometry and mathematical physics.

Special Breakthrough Prize in Fundamental Physics

Gerard ‘t Hooft, winner of the Special Breakthrough Prize in Fundamental Physics, is one of the world’s most pre-eminent theoretical physicists. In the early 1970s he made crucial contributions to the foundations of what would later become known as the Standard Model of the subatomic particles. He proved that Yang-Mills theories (the mathematical framework underlying theories of both the weak and strong nuclear forces) make sense when treated quantum mechanically – that they can give finite, calculable results rather than meaningless infinities – thus validating theories which became central to the Standard Model. He made several crucial contributions to understanding the theory of the strong force, including resolving a major problem involving the masses of particles through special field configurations called instantons; he developed new mathematical tools for studying strongly interacting quarks; and he introduced the fruitful approach of studying the strong force by imagining it is mediated by many more varieties of quarks and gluons than it actually is. These and other contributions helped establish the Standard Model as a workable theory and provided powerful tools for calculating its predictions. ‘t Hooft has studied the quantum effects that can explain how information is processed in black holes, which led to the development of the holographic principle in cosmology, and possibly to new alternative ways to interpret quantum mechanics. 

New Horizons in Physics Prize

This year’s New Horizons in Physics Prizes honor early-career researchers across a wide range of fields. In atomic physics, Waseem Bakr has created quantum gas microscopes that can image individual atoms confined in an optical lattice, advancing the study of strongly interacting quantum systems. In quantum information, a field at the fertile intersection of physics, mathematics and computer science, Jeongwan Haah has developed models of emergent quantum systems –macroscopic systems exhibiting quantum behavior, whose potential applications include quantum computing; these models include ‘Haah’s code’, which has opened the field of a class of quasi-particles called fractons. And in astronomy, Sebastiaan Haffert, Rebecca Jensen-Clem and Maaike van Kooten have designed and enabled novel techniques for extreme adaptive optics, which are systems that compensate for the effects of Earth’s atmosphere on light reaching terrestrial telescopes. Their work promises to enable the direct detection of the smallest exoplanets.

New Horizons in Mathematics Prize

Modern physics and higher mathematics share intimate connections, and it is notable that the research areas of all three of this year’s New Horizons in Mathematics Prize winners have links to quantum physics. Ewain Gwynne is recognized for his work in conformal probability, which studies probabilistic objects such as random curves and surfaces. John Pardon has produced a number of important results in geometry and topology, particularly in the field of symplectic geometry and pseudo-holomorphic curves, which are certain types of smooth surfaces in manifolds. Sam Raskin has played a significant role in the major recent progress on the geometric Langlands program (see Mathematics section above), including the final proof of the geometric Langlands conjecture in characteristic 0.

Maryam Mirzakhani New Frontiers Prize

The Maryam Mirzakhani New Frontiers Prize is awarded to outstanding women mathematicians who have recently completed their PhDs. Si Ying Lee has found a new approach to an important problem in the Langlands program (see Mathematics section above), succeeding in reducing it to a local problem. Rajula Srivastava has made progress in a challenging area at the intersection of harmonic analysis and number theory. Her work focuses on bounding the number of lattice points one can find near a given smooth surface, with important applications to Diophantine approximation in higher dimensions. Ewin Tang has invented quantum computing algorithms for machine learning. She also proved that certain calculations, which quantum algorithms were widely considered to be exponentially faster at solving, can actually be solved in comparable time by a normal (non-quantum) computer. 

 

Citations for 2025 Laureates

2025 Breakthrough Prize in Life Sciences

Daniel J. Drucker
Lunenfeld-Tanenbaum Research Institute, Sinai Health, and University of Toronto

Joel Habener 
Massachusetts General Hospital and Harvard University

Jens Juul Holst 
Novo Nordisk Foundation Center for Basic Metabolic Research and the Department of Biomedical Sciences, University of Copenhagen

Lotte Bjerre Knudsen
Novo Nordisk

Svetlana Mojsov
Rockefeller University

For the discovery and characterization of GLP-1 and revealing its physiology and potential in treating diabetes and obesity.

2025 Breakthrough Prize in Life Sciences

Alberto Ascherio
Harvard University

Stephen L. Hauser
University of California, San Francisco

For establishing the role of B cells in multiple sclerosis and developing B-cell based treatments, and for revealing that Epstein-Barr virus infection is the leading risk for multiple sclerosis.

2025 Breakthrough Prize in Life Sciences

David R. Liu
Merkin Institute for Transformative Technologies in Healthcare at the Broad Institute of MIT and Harvard, Harvard University, and Howard Hughes Medical Institute

For developing base editing and prime editing, technologies that edit the DNA of living systems without cutting the DNA double helix, and rewrite segments of genes at their native locations, enabling the correction or replacement of virtually any mutation.

2025 Breakthrough Prize in Fundamental Physics

The ATLAS, CMS, ALICE and LHCb Collaborations at CERN‘s Large Hadron Collider

For detailed measurements of Higgs boson properties confirming the symmetry-breaking mechanism of mass generation, the discovery of new strongly interacting particles, the study of rare processes and matter-antimatter asymmetry, and the exploration of nature at the shortest distances and most extreme conditions at CERN’s Large Hadron Collider.

The $3 million prize is allocated to ATLAS ($1 million); CMS ($1 million), ALICE ($500,000) and LHCb ($500,000), in recognition of 13,508 co-authors of publications based on LHC Run-2 data released between 2015 and July 15, 2024. [ATLAS – 5,345 researchers; CMS – 4,550; ALICE – 1,869; LHCb – 1,744]. 

In consultation with the leaders of the experiments, the Breakthrough Prize Foundation will donate 100 percent of the prize funds to the CERN & Society Foundation. The prize money will be used by the collaborations to offer grants for doctoral students from member institutes to spend research time at CERN, giving the students experience working at the forefront of science and new expertise to bring back to their home countries and regions.

The names of each prizewinner can be found at https://breakthroughprize.org/Laureates/1.

2025 Special Breakthrough Prize in Fundamental Physics

Gerardus ‘t Hooft
Utrecht University
For fundamental insights into gauge theory and the standard model.

2025 Breakthrough Prize in Mathematics

Dennis Gaitsgory
Max Planck Institute for Mathematics
For foundational works and numerous breakthrough contributions to the geometric Langlands program and its quantum version; in particular, the development of the derived algebraic geometry approach and the proof of the geometric Langlands conjecture in characteristic 0.

2025 New Horizons in Mathematics Prize

Ewain Gwynne
University of Chicago
For contributions to conformal probability, in particular to the understanding of the LQG metric.

John Pardon
Stony Brook University
For contributions to symplectic topology and other areas of geometry and topology.

Sam Raskin
Yale University
For contributions to the geometric Langlands program, including the theory of the Whittaker model and the proof of the geometric Langlands conjecture in characteristic 0.

2025 Maryam Mirzakhani New Frontiers Prize

Si Ying Lee
Stanford University
(PhD Harvard University 2022)
For contributions to the theory of Shimura varieties.

Rajula Srivastava
University of Bonn and Max Planck Institute for Mathematics
(PhD University of Wisconsin 2022)
For contributions in harmonic analysis and analytic number theory, including contributions to the problem of counting rational points near smooth manifolds.

Ewin Tang
University of California, Berkeley
(PhD University of Washington 2023)
For developing classical analogs of quantum algorithms for machine learning and linear algebra, and for advances in quantum machine learning on quantum data.

2025 New Horizons in Physics Prize

Waseem Bakr
Princeton University
For the realization of quantum gas microscopes for atoms and molecules, providing a microscopic view on correlations and transport in strongly interacting quantum systems.

2025 New Horizons in Physics Prize

Jeongwan Haah
Stanford University
For the discovery of Haah’s code, in which fractal conservation laws emerge, and other models bringing discrete mathematical structures to physics

2025 New Horizons in Physics Prize

Sebastiaan Haffert 
Leiden University, Leiden Observatory and University of Arizona, Steward Observatory

Rebecca Jensen-Clem
University of California, Santa Cruz 

Maaike van Kooten
National Research Council Canada
For demonstrating new extreme adaptive optics techniques that will allow the direct detection of the smallest exoplanets.

About The Breakthrough Prize
For the 13th year, the Breakthrough Prize, renowned as the “Oscars® of Science,” recognizes the world’s top scientists. Each prize is $3 million and presented in the fields of Life Sciences, Fundamental Physics and Mathematics. In addition, up to three New Horizons in Physics Prizes, up to three New Horizons in Mathematics Prizes and up to three Maryam Mirzakhani New Frontiers Prizes are given out to early-career researchers each year. Laureates attend a gala award ceremony designed to celebrate their achievements and inspire the next generation of scientists.

The Breakthrough Prizes were founded by Sergey Brin, Priscilla Chan and Mark Zuckerberg, Julia and Yuri Milner, and Anne Wojcicki and have been sponsored by foundations established by them. Selection Committees composed of previous Breakthrough Prize laureates in each field choose the winners. Information on the Breakthrough Prize is available at https://breakthroughprize.org.

 

Breakthrough Prize Foundation Announces Student Winner of 10th Annual Breakthrough Junior Challenge Science Video Competition

Jasmine Eyal, Age 16, of Singapore, Receives Top Honors and $400,000 in Education Prizes for her Original Video Explaining Mechanogenetic Cellular Engineering

LOS ANGELES, April 6, 2025 /PRNewswire/ — The Breakthrough Prize Foundation today announced Singapore-based Jasmine Eyal as winner of the 10th annual Breakthrough Junior Challenge, a global science video competition designed to inspire creative thinking and communications skills around fundamental concepts in the life sciences, physics, and mathematics.

The Breakthrough Junior Challenge will award a total of $400,000 in educational prizes to Jasmine and her science teacher Julie Li-Eyal. Jasmine will receive a $250,000 college scholarship. In her role as science teacher, Ms. Li-Eyal will receive a $50,000 prize. The prize also includes a state-of-the-art science lab designed by Cold Spring Harbor Laboratory valued at $100,000, which will be given to Community High School, part of the Beginning with Children Education Network in Brooklyn, NY.

Jasmine was honored alongside the 2025 Breakthrough Prize laureates at The Breakthrough Prize Ceremony in Los Angeles.

“This is the tenth year of the Junior Challenge, and every year I’m very impressed by the quality of the submissions,” said Julia Milner, co-founder of the Breakthrough Prize. “Jasmine’s video is a great example of where curiosity can lead you. She was researching potential treatments for her grandma’s diabetes, and it inspired her to explain the idea in a really smart, original and funny way.”

Jasmine’s winning entry explains mechanogenetic cellular engineering, an innovative biotechnology, exploring how it works and its potential as a medical tool in the future. The short film can be seen here. The entry marks Jasmine’s second time as a competition finalist, having entered the Breakthrough Junior Challenge in 2023.

“I am so honored to receive this award. My grandma, Popo, struggles with Type 1 diabetes, and I was inspired to learn more about this field of biology because of its potential to revolutionize health and medicine, treat chronic illnesses, and improve health outcomes,” said Jasmine. “The intersection of biology and technology in cellular engineering is an area where breakthroughs can dramatically improve the quality of life for countless individuals, including Popo.”   

Her grandmother, who co-stars in the video, was the first person to share with Jasmine the news of her win, in a video which can be seen here.

“I was so pleased when Jasmine asked me to participate in her entry and was delighted to be the one to share the news with her,” said Anne Li, Jasmine’s grandmother. “Jasmine has been an enthusiastic learner her entire life, and her mother has been an outstanding homeschool educator, connecting everyday experiences to science. She encourages Jasmine to approach the world with scientific curiosity, teaching her to hypothesize, experiment, and analyze results critically.”

“We are incredibly grateful for this generous gift, which will be a true blessing for our students and the entire Community High School family,” said Esosa Ogbahon, Superintendent of Beginning with Children and Community High School Principal. “Science is a critical and ever-evolving field and having access to a dedicated lab will allow our students to engage in hands-on learning, deepen their curiosity, and explore the endless possibilities that science offers. This opportunity will not only enrich our curriculum but also inspire the next generation of scientists, innovators, and problem-solvers.” 

The Breakthrough Junior Challenge is a global initiative to develop and demonstrate young people’s knowledge of science and scientific principles; generate excitement in these fields; support STEM career choices; and engage the imagination and interest of the public-at-large in key concepts of fundamental science.  Each year, students ages 13-18 are invited to create original videos (up to two minutes in length) that illustrate a concept or theory in life sciences, physics or mathematics. Submissions are evaluated based on the students’ ability to communicate complex scientific ideas in the most engaging, illuminating and imaginative ways.

“Jasmine and all the incredible finalists demonstrate a passion for learning – and a passion for sharing learning with others,” said Sal Khan. “Khan Academy is proud to partner with the Challenge to encourage and support students around the world as they explore deep concepts in science and math.”

This year, the Breakthrough Junior Challenge attracted more than 2,300 applicants from around the world. Submissions were narrowed down to 30 semifinalists, which represented the top submissions after two rounds of judging: first, a mandatory peer review, followed by an evaluation panel of judges. Sixteen finalists were selected in September 2024.

Now in its 10th year, the Breakthrough Junior Challenge has attracted more than 100,000 students, parents and teachers, and received applications from more than 30,000 students from over 200 countries across the globe, including Canada, India, Mauritius, Peru, the Philippines, Singapore, and the United States. The Challenge has awarded more than $2.5 million in college scholarships, $1 million for science labs, and $500,000 in awards to inspiring teachers in science or math. Previous winners have created videos about the Einstein’s Theory of Relativity, Circadian Rhythms, Neutrino Astronomy, Quantum Physics, and more. Award alumni have gone on to attend institutions including MIT, Harvard, Princeton, and Stanford. 

This year’s Selection Committee was comprised of: Ian Agol, professor of mathematics, University of California, Berkeley, and Breakthrough Prize in Mathematics laureate; Rachel Crane, former space and science correspondent, CNN; Pascale Ehrenfreund, PhD, president, Committee on Space Research COSPAR; John Grunsfeld, PhD, NASA astronaut and administrator; Mae Jemison, science literacy expert, former astronaut, and principal, 100 Year Starship; Jeffrey W. Kelly, professor of chemistry, Scripps Research Institute and Breakthrough Prize in Life Sciences laureate; Scott Kelly, retired NASA astronaut; Salman Khan, founder and CEO, Khan Academy; Ijad Madisch, CEO, co-founder, ResearchGate; Samaya Nissanke, University of Amsterdam, Breakthrough Prize in Fundamental Physics laureate; Nicole Stott, NASA astronaut; Andrew Strominger, professor of physics, Harvard University, and Breakthrough Prize in Fundamental Physics laureate; Terence Tao, UCLA professor and Breakthrough Prize in Mathematics laureate; Esther Wojcicki, founder, Palo Alto High Media Arts Center; Richard Youle, National Institutes of Health, and Breakthrough Prize in Life Sciences laureate; and S. Pete Worden, chairman, Breakthrough Prize Foundation and executive director, Breakthrough StarShot.

Submissions for the 2025 Breakthrough Challenge open on May 1st

Partners

The Breakthrough Junior Challenge
The Breakthrough Junior Challenge, founded by Julia and Yuri Milner, is a global science video competition, aiming to develop and demonstrate young people’s knowledge of science and scientific principles and communications skills; generate excitement in these fields; support STEM career choices; and engage the imagination and interest of the public-at-large in key concepts of fundamental science.

The Breakthrough Prize
The Breakthrough Prize, renowned as the “Oscars of Science,” recognizes the world’s top scientists. Each prize is $3 million and presented in the fields of Life Sciences, Fundamental Physics (one per year) and Mathematics (one per year). In addition, up to three New Horizons in Physics Prizes, up to three New Horizons in Mathematics Prizes and up to three Maryam Mirzakhani New Frontiers Prizes are given out to early-career researchers each year. Laureates attend a gala award ceremony designed to celebrate their achievements and inspire the next generation of scientists.

The Breakthrough Prizes were founded by Sergey Brin, Priscilla Chan and Mark Zuckerberg, Julia and Yuri Milner, and Anne Wojcicki. The Prizes have been sponsored by the personal foundations established by Sergey Brin, Priscilla Chan and Mark Zuckerberg, Julia and Yuri Milner and Anne Wojcicki. Selection Committees composed of previous Breakthrough Prize laureates in each field choose the winners. Information on the Breakthrough Prize is available at breakthroughprize.org.

About Khan Academy
Khan Academy is a 501(c)(3) nonprofit organization with the mission of providing a free, world-class education for anyone, anywhere. Khan Academy is piloting an AI guide called Khanmigo that is a tutor and teaching assistant. Khanmigo is integrated into a platform that includes practice problems, videos and articles that cover a range of subjects. Khan Academy’s free app for young children ages two to eight is Khan Academy Kids. The organization partners with school districts across the country that serve students who are historically under-resourced. Districts use Khan Academy Districts, MAP Accelerator and Khan Academy Kids to help teachers differentiate instruction. Worldwide, more than 160 million registered learners have used Khan Academy in 190 countries and 51 languages. For more information, please see research findings about Khan Academy and our press center.

Cold Spring Harbor Laboratory (CSHL)
The Breakthrough Prize Lab for the winning student’s school is designed in partnership with Cold Spring Harbor Laboratory (CSHL). Founded in 1890, CSHL is an independent 501(c)(3) nonprofit that powers transformation discoveries in cancer, neuroscience, plant biology, artificial intelligence, and quantitative biology. Merging world-renowned science and education divisions, CSHL nurtures a culture of curiosity, discovery, and innovation to make lives better. CSHL’s DNA Learning Center (DNALC) is the largest provider of hands-on instruction in genetics and biotechnology – operating five centers in the NY metro area, encompassing 20 teaching and bioinformatics labs. Each year 36,000 middle and high school students conduct experiments with DNALC faculty; an additional 2,000 participate in intensive, 5-day summer camps and mentored research projects. For more information visit www.cshl.edu.

Contact
For more information, including competition rules, video submission guidelines and queries, go to: breakthroughjuniorchallenge.org.